Please login to the form below

Not currently logged in

Chugai Pharma

This page shows the latest Chugai Pharma news and features for those working in and with pharma, biotech and healthcare.

Chugai soars on Roche buyout rumours

Chugai soars on Roche buyout rumours

Chugai soars on Roche buyout rumours. Reports circulating that Swiss company is poised to make $10bn offer. ... Shares in Japanese pharma company Chugai are riding high amid growing speculation that Roche is poised to buy out the firm.

Latest news

  • Chugai appoints US CMO Chugai appoints US CMO

    Japanese company Chugai Pharma has named Dr Athos Gianella-Borradori as chief medical officer of its US subsidiary. ... Cyclacel. The appointment at Chugai Pharma marks Dr Gianella-Borradori's first US role.

  • Chugai sets up antibody research company in Singapore

    Chugai sets up antibody research company in Singapore. Chugai Pharmabody Research will focus on generating new antibody drugs. ... Japanese pharma company Chugai is to set up a new research company based in Singapore.

  • A rush for sweet success

    US. Tramadol HCl extended-release tablets. RYZOLTTM (Purdue Pharma). Chronic pain. US. ... The GLP-1 pipeline includes five phase III compounds – albiglutide (Syncria, GSK, Human Genome Sciences), LY2189265 (Eli Lilly), taspoglutide (Roche, Chugai) and

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...